Cargando…

Development of a New Type of Prolonged Release Hydrocodone Formulation Based on Egalet® ADPREM Technology Using In Vivo–In Vitro Correlation

A novel abuse deterrent, prolonged release tablet formulation of Hydrocodone for once-daily dosing has been developed, based on the novel proprietary Egalet® ADPREM technology. The tablet is an injection molded polymer system consisting of an erodible matrix in which the Active Pharmaceutical Ingred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemmingsen, Pernille H., Haahr, Anne-Mette, Gunnergaard, Christine, Cardot, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857038/ https://www.ncbi.nlm.nih.gov/pubmed/24310426 http://dx.doi.org/10.3390/pharmaceutics3010073

Ejemplares similares

Extended-release hydrocodone – gift or curse?
por: Krashin, Daniel, et al.
Publicado: (2013)

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers
por: Farr, Stephen J, et al.
Publicado: (2015)

Assessment of Alcohol-Induced Dose Dumping with a Hydrocodone Bitartrate Extended-Release Tablet Formulated with CIMA(®) Abuse Deterrence Technology
por: Darwish, Mona, et al.
Publicado: (2015)

Prolonged Ventricular Asystole: A Rare Adverse Effect of Hydrocodone Use
por: Sudhakaran, Sivakumar, et al.
Publicado: (2014)

Abuse Potential with Oral Route of Administration of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Darwish, Mona, et al.
Publicado: (2017)

Evaluation of the Relative Intranasal Abuse Potential of a Hydrocodone Extended-Release Tablet Formulated with Abuse-Deterrence Technology in Nondependent, Recreational Opioid Users
por: Bond, Mary, et al.
Publicado: (2018)

Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
por: Ben-Joseph, Rami, et al.
Publicado: (2016)

Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminophen
por: Devarakonda, Krishna, et al.
Publicado: (2015)

Critical appraisal of extended-release hydrocodone for chronic pain: patient considerations
por: Gould, Harry J, et al.
Publicado: (2015)

Patterns of abuse and routes of administration for immediate‐release hydrocodone combination products
por: Cassidy, Theresa A., et al.
Publicado: (2017)

Comparison of single-dose and multiple-dose pharmacokinetics between two formulations of hydrocodone bitartrate/acetaminophen: immediate-release versus biphasic immediate-release/extended release
por: Devarakonda, Krishna, et al.
Publicado: (2015)

Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain
por: Hale, Martin E, et al.
Publicado: (2015)

Real-world utilization of once-daily extended-release abuse deterrent formulation of hydrocodone: a comparison with the pre-approval randomized clinical trials
por: Taber, Louise, et al.
Publicado: (2017)

Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain
por: Pergolizzi, Joseph, et al.
Publicado: (2018)

Hydrocodone, Oxycodone, and Morphine Metabolism and Drug–Drug Interactions
por: Coates, Shelby, et al.
Publicado: (2023)

Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review
por: Cardia, Luigi, et al.
Publicado: (2018)

Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
por: Harris, Stephen C., et al.
Publicado: (2016)

Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
por: Harris, Stephen C., et al.
Publicado: (2017)

U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study
por: Covvey, Jordan R., et al.
Publicado: (2015)

Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone
por: Weiner, Scott G., et al.
Publicado: (2022)

An Analysis of Oxycodone and Hydrocodone Distribution Trends in Delaware, Maryland, and Virginia Between 2006 and 2014
por: Eufemio, Conor M, et al.
Publicado: (2023)

A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain
por: Nalamachu, Srinivas, et al.
Publicado: (2014)

Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations
por: Girardi, Paolo, et al.
Publicado: (2016)

The Decline in Hydrocodone/Acetaminophen Prescriptions in Emergency Departments in the Veterans Health Administration Between 2009 to 2015
por: Grasso, Michael A., et al.
Publicado: (2016)

Development of In Vitro–In Vivo Correlation for Upadacitinib Extended-Release Tablet Formulation
por: Mohamed, Mohamed-Eslam F., et al.
Publicado: (2019)

Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic
por: Ngo, John, et al.
Publicado: (2020)

Bioavailability of Oniria(®), a Melatonin Prolonged-Release Formulation, Versus Immediate-Release Melatonin in Healthy Volunteers
por: Román Martinez, Manuel, et al.
Publicado: (2022)

Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials
por: Devarakonda, Krishna, et al.
Publicado: (2015)

Pharmacokinetics and Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone, After Intranasal Administration in Recreational Drug Users
por: Mickle, Travis C, et al.
Publicado: (2018)

Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers
por: Guenther, Sven M, et al.
Publicado: (2018)

A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough
por: Sloan, Victor S., et al.
Publicado: (2019)

In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
por: Shi, Changzhi, et al.
Publicado: (2023)

Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients
por: Lu, Zheng, et al.
Publicado: (2019)

The Formulation of Curcumin: 2-Hydroxypropyl-β-cyclodextrin Complex with Smart Hydrogel for Prolonged Release of Curcumin
por: Nikolić, Ljubiša, et al.
Publicado: (2023)

Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice
por: Wong, Woonyen, et al.
Publicado: (2023)

Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study
por: Gaur, Praveen Kumar, et al.
Publicado: (2014)

Development and validation of an in vitro–in vivo correlation (IVIVC) model for propranolol hydrochloride extended-release matrix formulations
por: Cheng, Chinhwa, et al.
Publicado: (2013)

Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron
por: Ottoboni, Thomas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2suro9lems7q9vn6oi08eodk9i